Summary
Islet amyloid may have a pathological role in the development of Type 2 (non-insulin-dependent) diabetes mellitus. The prevalence of islet amyloid has been investigated on post-mortem pancreatic tissue from both diabetic and non-diabetic Pima Indian subjects who had previously been assessed by oral glucose tolerance tests. Islets were examined for amyloid deposits and for cellular immunoreactivity to pancreatic hormones and islet amyloid polypeptide, the constituent peptide of islet amyloid. Twenty of 26 diabetic subjects (77%) had islet amyloid, compared with one of 14 non-diabetic subjects (7%). Twelve of the diabetic subjects (46%) had amyloid in more than 10% of their islets, whereas only 4% of islets were affected in a single non-diabetic subject. Positive immunoreactivity for islet amyloid peptide was present in the islet amyloid and in islet cells in 54% of the diabetic and 50% of the non-diabetic subjects. Islet amyloid in diabetic Pima Indians may indicate a primary Beta-cell defect which interacts with insulin resistance to produce diabetes, or may develop as a result of Beta-cell dysfunction induced by insulin resistance and hyperglycaemia.
Article PDF
Similar content being viewed by others
References
Opie E (1901) The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islets of Langerhans. J Exp Med 5: 527–540
Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR, Turner RC (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in Type 2 diabetes. Diabetes Res 9: 151–160
Schneider HM, Storkel S, Will W (1980) Das Amyloid der Langerhansschen Inseln und seine Beziehung zum Diabetes Mellitus. Dtsch Med Wochenschr 105: 1143–1147
Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30: 887–892
Vishwanathan KA, Bazaz-Malik G, Dandekar J, Vaishnava (1972) A qualitative and quantitative histological study of the islets of Langerhans in diabetes mellitus. Indian J Med Sci 26: 807–812
Saito K, Takahashi T, Yaginuma N, Iwama N (1978) Islet morphometry in the diabetic pancreas of man. Tohoku J Exp Med 125: 185–197
Bell ET (1959) Hyalinization of the islets of Langerhans in non-diabetic individuals. Am J Pathol 35: 801–805
Maloy AL, Longnecker DS, Greenberg ER (1981) The relation of islet amyloid to the clinical type of diabetes. Human Pathol 12: 917–922
Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC (1987) Islet amyloid formed from diabetes associated peptide may be pathogenic in type 2 diabetes. Lancet II: 231–234
Anonymous (1987) Pancreatic abnormalities in type 2 diabetes mellitus. Editorial, Lancet II: 1497–1498
Howard CF (1986) Longitudinal studies on the development of diabetes in individual macaca nigra. Diabetologia 29: 301–306
Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci 84: 3881–3885
Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterisation of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Nat Acad Sci 84: 8628–8632
Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene-related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 826–831
Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KBM (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci 85: 7763–7766
Betscholz C, Christmansson L, Engstrom U, Rosman F, Svensson V, Johnson KH, Westermark P (1989) Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains the differences in islet amyloid formation between species. FEBS Let 251: 261–264
Nishi M, Chan SS, Naganatsu S, Bell GI, Steiner DF (1989) Conservation of the sequence of islet amyloid polypeptide in 5 mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA 86: 5738–5742
Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414–417
Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108: 497–505
Knowler WC, Pettitt DJ, Savage PJ, Bennett PH (1981) Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113: 144–156
Knowler WC, Pettitt DJ, Bennett PH, Williams RC (1983) Diabetes mellitus in the Pima Indians: genetic and evolutionary considerations. Am J Phys Anthrop 61: 107–114
Savage PJ, Dippe SE, Bennett PH et al. (1975) Hyperinsulinemia and hypoinsulinemia. Insulin response to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes 24: 362–368
Nagulesparan M, Savage PJ, Mott DM, Johnson GC, Unger RH, Bennett PH (1980) Increased insulin resistance in obese, glucose intolerance southwestern American Indians: evidence for a defect not explained by obesity. J Clin Endocrinol Metab 51: 739–743
Bogardus C, Lillioja S, Foley J, Christin L, Freymond D, Nyomba B, Bennett PH, Reaven G, Salans L (1987) Insulin resistance predicts the development of non-insulin-dependent diabetes mellitus in Pima Indians. Diabetes 36: 47 (A)
Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217–1225
Lillioja S, Bogardus C (1988) Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev 4: 517–540
Report of a WHO Study Group (1985) Diabetes mellitus. WHO Tech Rep Ser 7272: 9–17
Nakane PK, Pierce GB (1967) Enzyme labelled antibodies for the light and electron microscopic localisation of tissue antigens. J Cell Biol 33: 307–318
Savage PJ, Bennett PH, Senter RG, Miller M (1979) High prevalence of diabetes in young Pima Indians. Diabetes 28: 937–942
Katzeff HL, Savage PJ, Barclay-White B, Nagulesparan M, Bennett PH (1985) C-peptide measurements in the differentiation of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 17: 161–164
Clark A, Holman RR, Matthews DR, Hockaday TDR, Turner RC (1984) Non-uniform distribution of islet amyloid in the pancreas of ‘maturity-onset’ diabetic patients. Diabetologia 27: 527–528
Johnson KH, O'Brien TD, Hayden DW, Ghobrial HKG, Westermark P (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase antiperoxidase (PAP) and protein A gold techniques. Am J Pathol 130: 1–8
Clark A, Edwards CA, Ostle LR, Sutton R, Rothbard JB, Morris JF, Turner RC (1988) Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tiss Res 257: 179–185
Mosselman S, Hoppener JWM, Zandberg J, van Mansfield ADM, Geurts van Kessel AHM, Lips CJM, Jansz HS (1988) Islet amyloid polypeptide (IAPP): identification and chromosomal localization of the human gene. Febs Lett 239: 227–232
Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89 amino acid precursor by proteolytic processing. J Biol Chem 263: 17243–17246
Westermark P, Wilander E, Johnson KH (1987) Islet amyloid polypeptide. Lancet II: 623
Ohsawa H, Kanatsuku A, Yamaguchi T, Makino H, Yoshida S (1989) Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets Diabetologia 32: 524A
Turner RC, Heding LG (1977) Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 13: 571–577
Clark A, Matthews DR, Naylor BA, Wells CA, Hosker JP, Turner RC (1987) Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes. Diabetes Res 4: 51–55
O'Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318: 1225–1230
Turner RC, Rudenski AS, Holman RR, Matthews DR, O'Rahilly SP (1987) Quantitative modelling of endocrine diseases. Clin Endocrinol 26: 107–116
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, A., Saad, M.F., Nezzer, T. et al. Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 33, 285–289 (1990). https://doi.org/10.1007/BF00403322
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403322